LIFE: Presentation of Forget Diabetes project

Bergen, Norway 8 November 2021

Please find enclosed the presentation held by Lifecare AS' CSO Prof. Andreas
Pfützner at the 20th annual Diabetes Tech Meeting 6 November 2021. Topic of the
presentation was the EU funded project Forget Diabetes: a novel automated
insulin delivery system, of which Lifecare in cooperation with 6 academic
partners cross Europe aim to develop an artificial pancreas where the sensing
system is based on the Sencell technology. 

This is Lifecare
Lifecare is a Bergen-based technology company developing a miniaturized
implantable long-term sensor for correct and continuous monitoring of blood
sugar in people with diabetes. The Company's patented technology also has the
potential for use in various biomarkers. Lifecare AS is listed on Euronext
Growth (LIFE).

Further information Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no,
+47 40 05 90 40 

This stock exchange announcement was published by Kine Hereid, Investor
Relations at Lifecare AS, on 08.11.2021 at 08.30 CET.